Suggested for you
Explore suggested content tailored to your role within the CAR T-cell therapy journey
23-minute watch
EHA: Follow the patient pathway to survival in 2L DLBCL
Planning ahead for 2L
Prof. Graham Collins, Dr Mariana Bastos-Oreiro
10-minute watch
EHA: Follow the patient pathway to survival in 2L DLBCL
Delivering CAR T
Dr Pierre Sesques
18-minute watch
EHA: Follow the patient pathway to survival in 2L DLBCL
Choosing CAR T with curative intent
Dr Natasha Kekre
13-minute watch
EHA: Follow the patient pathway to survival in 2L DLBCL
CAR T survivorship and summary
Prof. Graham Collins, Dr Mariana Bastos-Oreiro, Dr Pierre Sesques
Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023
Keep up to date
Be the first to find out about Kite Cell Therapy Hub's upcoming content launches
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.